Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06906302

RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV

Recovering From IPV Through Strengths and Empowerment (RISE) Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
172 (estimated)
Sponsor
Boston University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced IPV in the past 12 months: Recovering from IPV through Strength and Empowerment (RISE) and advocacy-based Enhanced Care as Usual (ECAU). The RISE intervention includes up to 8 sessions and includes specific topic areas (e.g., social support, health effects, resources). The other intervention, ECAU, includes a single session that includes supportive education about IPV and health effects, discussion of ways to increase safety, and information about resources. This study will test which approach is better for improving self-efficacy and other aspects of health. Participants will answer surveys about their self-efficacy and other health and safety indicators (e.g., mental health symptoms) right before receiving treatment, approximately 12 weeks later, and then every three months after that for one year. Participation in this research will last about 15 months.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRISERISE is personalized, trauma-informed, empowerment-oriented and variable-length, consisting of an initial 60-minute session and up to 7 additional 45-minute sessions (1-8 sessions total).
BEHAVIORALAdvocacy-based ECAUAdvocacy-based ECAU is a single 60-minute trauma-informed counseling intervention that includes supportive education, validating and empathetic statements, safety planning, resource provision and referrals.

Timeline

Start date
2025-09-15
Primary completion
2030-01-01
Completion
2030-01-01
First posted
2025-04-02
Last updated
2025-10-14

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06906302. Inclusion in this directory is not an endorsement.